[{"Assets_0_FY_USD":"1562700000.0","CIK":"899923","CommonStockSharesIssued_0_FY_shares":"73500000.0","CommonStockSharesOutstanding_0_FY_shares":"73500000.0","Country":"United States","EarningsPerShareBasic_1_FY_USD":"-0.06","EarningsPerShareBasic_4_FY_USD":"0.06","EarningsPerShareDiluted_1_FY_USD":"-0.06","EarningsPerShareDiluted_4_FY_USD":"0.06","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":"83700000.0","NetIncomeLoss_1_FY_USD":"-4200000.0","NetIncomeLoss_4_FY_USD":"4600000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_FY_USD":"-4300000.0","ProfitLoss_4_FY_USD":"4400000.0","RevenuesConverted_1_FY_USD":"215400000.0","RevenuesConverted_4_FY_USD":"851100000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_FY_USD":"1088900000.0","StockholdersEquity_0_FY_USD":"1088900000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":"74800000.0","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":"76000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":"73400000.0","WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":"73500000.0","filed":"20190813","footnote":null,"form":"10-K","fp":"FY","fy":"2019.0","name":"MYRIAD GENETICS INC","period":"20190630","qtrs":"0","uom":"USD"}]